blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2335720

EP2335720 - Autologous T-cell vaccines against multiple sclerosis [Right-click to bookmark this link]
Former [2011/25]Autologous T-cell vaccines materials and methods
[2012/31]
StatusNo opposition filed within time limit
Status updated on  07.02.2014
Database last updated on 21.09.2024
Most recent event   Tooltip07.02.2014Lapse of the patent in a contracting state
New state(s): SK
published on 12.03.2014  [2014/11]
07.02.2014No opposition filed within time limitpublished on 12.03.2014  [2014/11]
Applicant(s)For all designated states
Opexa Pharmaceuticals, Inc.
1709 Dryden Road Suite 911
Houston, TX 77030 / US
For all designated states
Baylor College Of Medicine
One Baylor Plaza
Houston, TX 77030 / US
[2011/25]
Inventor(s)01 / Zhang, Jingwu
2219 Parkview
Missouri City, TX 77459 / US
 [2013/14]
Former [2011/25]01 / Zhang, Jingwu
2219 Parkview
Missouri City, TX 77459 / US
Representative(s)Walton, Seán Malcolm, et al
Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2011/25]Walton, Seán Malcolm, et al
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Application number, filing date10178920.412.09.2002
[2011/25]
Priority number, dateUS2001095253214.09.2001         Original published format: US 952532
[2011/25]
Previously filed application, dateEP2008000459712.09.2002
[2011/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2335720
Date:22.06.2011
Language:EN
[2011/25]
Type: B1 Patent specification 
No.:EP2335720
Date:03.04.2013
Language:EN
[2013/14]
Search report(s)(Supplementary) European search report - dispatched on:EP21.04.2011
ClassificationIPC:A61P37/04, C12N5/0783, A61K35/14, A61K35/24
[2012/31]
CPC:
A61K39/0008 (EP,US); A61K38/17 (KR); A61K2239/31 (EP,KR,US);
A61K2239/38 (EP,KR,US); A61K39/4611 (EP,KR,US); A61K39/4621 (EP,KR,US);
A61K39/46432 (EP,KR,US); A61K39/46433 (EP,KR,US); A61P19/02 (EP);
A61P25/00 (EP); A61P25/28 (EP); A61P29/00 (EP);
A61P37/00 (EP); A61P37/04 (EP); A61P43/00 (EP);
C12N5/0636 (EP,KR,US) (-)
Former IPC [2011/25]A61K39/00, A61K39/38, A61K35/14, A61P37/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2011/25]
TitleGerman:Autologe T-Zelle-Impfstoffe gegen multiple Sklerose[2012/31]
English:Autologous T-cell vaccines against multiple sclerosis[2012/31]
French:Vaccins de lymphocyte T autologue contre la sclérose en plaques[2012/31]
Former [2011/25]Autologe T-Zelle-Impfstoffmaterialien und Verfahren
Former [2011/25]Autologous T-cell vaccines materials and methods
Former [2011/25]Matériaux et procédés de vaccins de lymphocyte T autologue
Examination procedure21.12.2011Amendment by applicant (claims and/or description)
21.12.2011Examination requested  [2012/05]
02.03.2012Despatch of a communication from the examining division (Time limit: M04)
03.05.2012Reply to a communication from the examining division
31.07.2012Despatch of a communication from the examining division (Time limit: M02)
10.10.2012Reply to a communication from the examining division
16.11.2012Communication of intention to grant the patent
11.02.2013Fee for grant paid
11.02.2013Fee for publishing/printing paid
Parent application(s)   TooltipEP02778249.9  / EP1416956
EP08004597.4  / EP1946767
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20020778249) is  10.01.2005
Opposition(s)06.01.2014No opposition filed within time limit [2014/11]
Fees paidRenewal fee
21.10.2010Renewal fee patent year 03
21.10.2010Renewal fee patent year 04
21.10.2010Renewal fee patent year 05
21.10.2010Renewal fee patent year 06
21.10.2010Renewal fee patent year 07
21.10.2010Renewal fee patent year 08
21.10.2010Renewal fee patent year 09
29.09.2011Renewal fee patent year 10
12.09.2012Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY03.04.2013
SK03.04.2013
BG03.07.2013
[2014/11]
Former [2013/52]CY03.04.2013
BG03.07.2013
Former [2013/50]BG03.07.2013
Documents cited:Search[I]WO9913904  (UNIV SOUTHERN CALIFORNIA [US]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.